These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28834378)

  • 21. Decrease of myofiber branching via muscle-specific expression of the olfactory receptor mOR23 in dystrophic muscle leads to protection against mechanical stress.
    Pichavant C; Burkholder TJ; Pavlath GK
    Skelet Muscle; 2016; 6():2. PubMed ID: 26798450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy.
    Murphy S; Dowling P; Zweyer M; Mundegar RR; Henry M; Meleady P; Swandulla D; Ohlendieck K
    J Proteomics; 2016 Aug; 145():24-36. PubMed ID: 26961938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute, next-generation AMPK activation initiates a disease-resistant gene expression program in dystrophic skeletal muscle.
    Ng SY; Mikhail AI; Mattina SR; Manta A; Diffey IJ; Ljubicic V
    FASEB J; 2023 May; 37(5):e22863. PubMed ID: 37016990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10.
    Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T
    Hum Mol Genet; 2014 Aug; 23(15):3990-4000. PubMed ID: 24659498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy.
    Mantuano P; Sanarica F; Conte E; Morgese MG; Capogrosso RF; Cozzoli A; Fonzino A; Quaranta A; Rolland JF; De Bellis M; Camerino GM; Trabace L; De Luca A
    Biochem Pharmacol; 2018 Aug; 154():89-103. PubMed ID: 29684379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skeletal muscle-specific overexpression of IGFBP-2 promotes a slower muscle phenotype in healthy but not dystrophic mdx mice and does not affect the dystrophic pathology.
    Swiderski K; Martins KJ; Chee A; Trieu J; Naim T; Gehrig SM; Baum DM; Brenmoehl J; Chau L; Koopman R; Gregorevic P; Metzger F; Hoeflich A; Lynch GS
    Growth Horm IGF Res; 2016; 30-31():1-10. PubMed ID: 27544574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
    Ito M; Ehara Y; Li J; Inada K; Ohno K
    Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
    Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
    Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AMP-activated protein kinase at the nexus of therapeutic skeletal muscle plasticity in Duchenne muscular dystrophy.
    Ljubicic V; Jasmin BJ
    Trends Mol Med; 2013 Oct; 19(10):614-24. PubMed ID: 23891277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulated Autophagy and Mitophagy in a Mouse Model of Duchenne Muscular Dystrophy Remain Unchanged Following Heme Oxygenase-1 Knockout.
    Mucha O; Kaziród K; Podkalicka P; Rusin K; Dulak J; Łoboda A
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy.
    Palladino M; Gatto I; Neri V; Straino S; Smith RC; Silver M; Gaetani E; Marcantoni M; Giarretta I; Stigliano E; Capogrossi M; Hlatky L; Landolfi R; Pola R
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2867-76. PubMed ID: 24072696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
    Yuasa K; Nakamura A; Hijikata T; Takeda S
    BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
    Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eliminating Nox2 reactive oxygen species production protects dystrophic skeletal muscle from pathological calcium influx assessed in vivo by manganese-enhanced magnetic resonance imaging.
    Loehr JA; Stinnett GR; Hernández-Rivera M; Roten WT; Wilson LJ; Pautler RG; Rodney GG
    J Physiol; 2016 Nov; 594(21):6395-6405. PubMed ID: 27555555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term dietary quercetin enrichment as a cardioprotective countermeasure in mdx mice.
    Ballmann C; Denney T; Beyers RJ; Quindry T; Romero M; Selsby JT; Quindry JC
    Exp Physiol; 2017 Jun; 102(6):635-649. PubMed ID: 28192862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestine of dystrophic mice presents enhanced contractile resistance to stretching despite morphological impairment.
    Alves GA; Silva LR; Rosa EF; Aboulafia J; Freymüller-Haapalainen E; Souccar C; Nouailhetas VL
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G191-9. PubMed ID: 24284964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with rGDF11 does not improve the dystrophic muscle pathology of mdx mice.
    Rinaldi F; Zhang Y; Mondragon-Gonzalez R; Harvey J; Perlingeiro RCR
    Skelet Muscle; 2016; 6():21. PubMed ID: 27303621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90.
    Young CN; Sinadinos A; Lefebvre A; Chan P; Arkle S; Vaudry D; Gorecki DC
    Autophagy; 2015; 11(1):113-30. PubMed ID: 25700737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
    Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
    Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skeletal muscle from aged American Quarter Horses shows impairments in mitochondrial biogenesis and expression of autophagy markers.
    Li C; White SH; Warren LK; Wohlgemuth SE
    Exp Gerontol; 2018 Feb; 102():19-27. PubMed ID: 29203401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.